Imagyn Medical Technologies has received Food and Drug Administration 510(k) clearance for its 22-mm SiteSelect stereotactic breast biopsy system. The 22-mm size will complement Imagyn's 10-mm and 15-mm devices, according to the Irvine, CA-based firm. Imagyn believes the new clearance allows for a larger core of suspicious breast tissue to be removed and diagnosed by a physician.
By AuntMinnie.com staff writersSeptember 26, 2001
Imagyn completes sale of MAS product line, July 10, 2001
Imagyn divests MAS assets, June 12, 2001
Imagyn buys Intl. Isotopes brachytherapy assets, May 1, 2001
Theragenics adds deal with Imagyn, September 22, 2000
Copyright © 2001 AuntMinnie.com
